|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-27
|
|
pubmed:abstractText |
We have shown that as renal function deteriorated, night-time fall in both blood pressure and urinary sodium excretion were diminished. We have also reported that sodium intake restriction and diuretics both normalized circadian blood pressure rhythm from nondipper to dipper patterns. In this study, we investigated whether an angiotensin II receptor blocker, olmesartan, could restore night-time blood pressure fall.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
583-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18300871-Adult,
pubmed-meshheading:18300871-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:18300871-Blood Pressure,
pubmed-meshheading:18300871-Blood Pressure Monitoring, Ambulatory,
pubmed-meshheading:18300871-Circadian Rhythm,
pubmed-meshheading:18300871-Female,
pubmed-meshheading:18300871-Humans,
pubmed-meshheading:18300871-Imidazoles,
pubmed-meshheading:18300871-Kidney Failure, Chronic,
pubmed-meshheading:18300871-Male,
pubmed-meshheading:18300871-Middle Aged,
pubmed-meshheading:18300871-Natriuresis,
pubmed-meshheading:18300871-Sodium,
pubmed-meshheading:18300871-Tetrazoles
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
|
|
pubmed:affiliation |
Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan. m-fukuda@med.nagoya-cu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
